Tamarix Pharma

Tamarix Pharma was founded in 2021 based on technology licensed from the National Institute for Biotechnology in the Negev (Israel) and is focused on developing novel technologies that restore physiological balance in apoptosis-related diseases.

The company’s lead assets, VBIT-4 and VBIT-12, are small molecules designed to target a key mitochondrial process known as VDAC1 oligomerization. VDAC1 oligomerization is a key process involved in apoptotic cell death that has been validated by multiple independent research groups as an anti-apoptotic target.

According to the company its unique mechanism of action represents a highly-differentiated approach to potentially treating a variety of acute and chronic conditions resulting from apoptotic cell death. Early exploration of indications for VBIT-4 and VBIT-12 will include: dry age-related macular degeneration (dry AMD) / geographic atrophy (GA); low-tension glaucoma – intraocular pressure (IOP) independent therapy; and central vein occlusion.

Tamarix plans to be Phase I ready by the end of 2023 and is says it is currently expanding its investor base to support development of VBIT-4 (primary focus) and VBIT-12.

Subscribe for alerts on new companies featured on Startups.Bio

Function Oncology
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer in unprecedented and patient-specific detail. By moving beyond measuring gene sequence to measuring …
Mallia Therapeutics
Founded in 2023, Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss. sCD83, which was discovered as an immune modulator by Mallia co-founder …
T-Therapeutics
T-Therapeutics is on a mission to unlock the power of T cells to treat chronic and infectious diseases. Founded in 2022, the company is based on technology from Professor Allan …
Empyrean Neuroscience
Empyrean Neuroscience has developed a platform for genetically engineering small molecule therapeutics from fungi and plants to treat neuropsychiatric and neurologic disorders. Through precision targeting and engineering of the fungal …

View all recently featured startups

Tags: